Item 5.02. Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On March 28, 2022, Alberto Mas, Executive Vice President and President of the
Medical segment of BD informed BD of his intention to retire, effective at the
end of BD's fiscal year on September 30, 2022. BD intends to name a successor to
Mr. Mas prior to his retirement date. To support a successful succession
process, Mr. Mas will be paid a one-time cash retention award of $300,000,
contingent upon his continuing active employment through September 30, 2022.
Item 7.01. Other Events.
On March 31, 2022, BD issued a press release relating to the matters described
above in Item 5.02. A copy of the press release is attached hereto as Exhibit
99.1 and is incorporated into this Item 7.01 by reference. The information in
this Item 7.01 shall neither be deemed "filed" for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (the "Exchange Act"), nor shall it
be deemed incorporated by reference in any filing under the Securities Act of
1933, as amended, or the Exchange Act.
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.
Exhibit 99.1 Press release dated March 31, 2022, which is furnished pursuant
to Item 7.01.
Exhibit 104 Cover Page Interactive Data File (embedded within the Inline XBRL
document).
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses
BECTON, DICKINSON AND COMPANY 
